Microbial Bioactives
The Exploitation of Microbes: Next Generation Global Solution
Md. Asaduzzaman Shishir a and Md. Mozammel Hoq b*
Microbial Bioactives 3(1) 106-109 https://doi.org/10.25163/microbbioacts.31001E2313150520
Submitted: 23 July 2019 Revised: 16 May 2020 Published: 18 May 2020
Solving Global Problems with Next Generation Microbial Application
Abstract
Microorganisms, though microscopic, hold immense potential to influence and transform nearly every sphere of life when utilized appropriately. Nature operates as a complex and dynamic system where interactions among biotic and abiotic components shape ecological balance, sometimes with delayed and unintended consequences (Dimkpa et al., 2009; Meier et al., 2010). Over time, many technological and industrial advances have led to significant global challenges, including antibiotic resistance, environmental pollution, bioaccumulation, and ecosystem disruption (MacGowan & Macnaughton, 2017; “Progress on antibiotic resistance,” 2018). These issues are further intensified by climate change and anthropogenic pressures, affecting health, agriculture, and environmental sustainability worldwide (Bellard et al., 2012; Hoegh-Guldberg & Bruno, 2010). In response, integrated and interdisciplinary approaches are increasingly being adopted, with microbial biotechnology emerging as a promising solution. Microorganisms possess unique attributes such as metabolic diversity, rapid growth, adaptability, and the ability to produce valuable bioactive compounds, making them essential tools in medicine, agriculture, industry, and environmental remediation (Ahmad et al., 2011; Claassens et al., 2016). Despite these advantages, developing countries remain underutilized in harnessing microbial potential. Therefore, strategic investment, technological integration, and policy-driven initiatives are crucial to promote sustainable, microbe-based innovations that can address global challenges while supporting economic growth and ecological resilience.
Keywords: Microbial technology; Natural process; Artefacts; Ecofriendly solutions.
References
Adams GP, Weiner LM. Monoclonal antibody therapy of cancer. Nature Biotechnology. 2005;23(9):1147–1157. https://doi.org/10.1038/nbt1137.
Ahasan MR, Partanen T. Occupational health and safety in the least developed countries: a simple case of neglect. Journal of Epidemiology. 2001;11(2):74–80. https://doi.org/10.2188/jea.11.74.
Ahmad I, Khan MSA, Aqil F, Singh M. Microbial applications in agriculture and the environment: a broad perspective. In: Ahmad I, Ahmad F, Pichtel J, editors. Microbes and Microbial Technology: Agricultural and Environmental Applications. New York, NY: Springer; 2011. https://doi.org/10.1007/978-1-4419-7931-5_1.
Bakker MG, Manter DK, Sheflin AM, Weir TL, Vivanco JM. Harnessing the rhizosphere microbiome through plant breeding and agricultural management. Plant and Soil. 2012;360:1–13. https://doi.org/10.1007/s11104-012-1361-x.
Barai L, Saha MR, Rahman T, Khandaker T, Dutta S, Hasan R, Haq JA. Antibiotic resistance: situation analysis in a tertiary care hospital of Bangladesh. Bangladesh Journal of Medicine. 2017;34:15–19.
Barkay T, Schaefer J. Metal and radionuclide bioremediation: issues, considerations and potentials. Current Opinion in Microbiology. 2001;4(3):318–323. https://doi.org/10.1016/S1369-5274(00)00210-1.
Bellard C, Bertelsmeier C, Leadley P, Thuiller W, Courchamp F. Impacts of climate change on the future of biodiversity. Ecology Letters. 2012;15(4):365–377. https://doi.org/10.1111/j.1461-0248.2011.01736.x.
Bérdy J. Bioactive microbial metabolites. The Journal of Antibiotics. 2005;58(1):1–26. https://doi.org/10.1038/ja.2005.1.
Bérdy J. Thoughts and facts about antibiotics: where we are now and where we are heading. The Journal of Antibiotics. 2012;65:385–395. https://doi.org/10.1038/ja.2012.27.
Biankin AV, Piantadosi S, Hollingsworth SJ. Patient-centric trials for therapeutic development in precision oncology. Nature. 2015;526(7573):361–370. https://doi.org/10.1038/nature15819.
Bonning BC. Bt toxin modification for enhanced efficacy. Toxins. 2014;6(10):3005–3027. https://doi.org/10.3390/toxins6103005.
Bushell M. Manual of Industrial Microbiology and Biotechnology. Washington, DC: ASM Press; 2003.
Claassens NJ, Sousa DZ, dos Santos VAPM, de Vos WM, van der Oost J. Harnessing the power of microbial autotrophy. Nature Reviews Microbiology. 2016;14:692–706. https://doi.org/10.1038/nrmicro.2016.130.
Demain AL. Importance of microbial natural products and the need to revitalize their discovery. Journal of Industrial Microbiology & Biotechnology. 2014;41(2):185–201. https://doi.org/10.1007/s10295-013-1325-z.
Dewapriya P, Kim S. Marine microorganisms: an emerging avenue in modern nutraceuticals and functional foods. Food Research International. 2014;56:115–125. https://doi.org/10.1016/j.foodres.2013.12.022.
Dimkpa C, Weinand T, Asch F. Plant-rhizobacteria interactions alleviate abiotic stress conditions. Plant, Cell & Environment. 2009;32(12):1682–1694. https://doi.org/10.1111/j.1365-3040.2009.02028.x.
Ferdous UT, Shishir MA, Khan SN, Hoq MM. Bacillus spp.: attractive sources of anti-cancer and anti-proliferative biomolecules. Microbial Bioactives. 2018;1(1):E033–E045. https://doi.org/10.25163/microbbioacts.11005B0408130818.
Fink MP, Warren HS. Strategies to improve drug development for sepsis. Nature Reviews Drug Discovery. 2014;13:741–758. https://doi.org/10.1038/nrd4368.
Gadd GM. Heavy metal accumulation by bacteria and other microorganisms. Experientia. 1990;46(8):834–840. https://doi.org/10.1007/BF01935534.
Grossel SS. Safety in industrial microbiology and biotechnology. Journal of Loss Prevention in the Process Industries. 1994;7(2):157–163. https://doi.org/10.1016/0950-4230(94)80080-4.
Hoegh-Guldberg O, Bruno JF. The impact of climate change on the world’s marine ecosystems. Science. 2010;328(5985):1523–1528. https://doi.org/10.1126/science.1189930.
Hoq MM, Mamun A Al, Shishir MA, Akand NR, Khan M, Khan SN. Bioprocess development for eco-friendly microbial products and its impacts on bio-industry establishment in Bangladesh. In: International Conference on Biotechnology. Vol. 1. Dhaka, Bangladesh; 2013:205–217. Available from: http://www.caresbd.org/uploads/book1_14.pdf.
Ilias M, Rafiqullah IM, Debnath BC, Mannan KSB, Mozammel Hoq M. Isolation and characterization of chromium(VI)-reducing bacteria from tannery effluents. Indian Journal of Microbiology. 2011;51(1):76–81. https://doi.org/10.1007/s12088-011-0095-4.
Kleinman A. Four social theories for global health. The Lancet. 2010;375(9725):1518–1519. https://doi.org/10.1016/S0140-6736(10)60646-0.
Löffler FE, Edwards EA. Harnessing microbial activities for environmental cleanup. Current Opinion in Biotechnology. 2006;17(3):274–284. https://doi.org/10.1016/j.copbio.2006.05.001.
Lustick DR, Zaman MH. Biomedical engineering education and practice: challenges and opportunities in improving health in developing countries. In: 2011 Atlanta Conference on Science and Innovation Policy. IEEE; 2011. p. 1–5. https://doi.org/10.1109/ACSIP.2011.6064477.
MacGowan A, Macnaughton E. Antibiotic resistance. Medicine. 2017;45(10):622–628. https://doi.org/10.1016/j.mpmed.2017.07.006.
Mahlapuu M, Håkansson J, Ringstad L, Björn C. Antimicrobial peptides: an emerging category of therapeutic agents. Frontiers in Cellular and Infection Microbiology. 2016;6:194. https://doi.org/10.3389/fcimb.2016.00194.
Mandal D, Bolander ME, Mukhopadhyay D, Sarkar G, Mukherjee P. The use of microorganisms for the formation of metal nanoparticles and their application. Applied Microbiology and Biotechnology. 2006;69:485–492. https://doi.org/10.1007/s00253-005-0179-3.
Meena KR, Sharma A, Kanwar SS. Microbial lipopeptides and their medical applications. Annals of Pharmacology and Pharmaceutics. 2017;2(21):1–5.
Meier ES, Kienast F, Pearman PB, Svenning JC, Thuiller W, Araújo MB, et al. Biotic and abiotic variables show little redundancy in explaining tree species distributions. Ecography. 2010;33(6):1038–1048. https://doi.org/10.1111/j.1600-0587.2010.06229.x.
Pandey A, Soccol CR, Nigam P, Soccol VT. Biotechnological potential of agro-industrial residues. I: Sugarcane bagasse. Bioresource Technology. 2000;74(1):69–80. https://doi.org/10.1016/S0960-8524(99)00142-X.
Patra JK, Das G, Shin HS, editors. Microbial Biotechnology. Singapore: Springer; 2018. https://doi.org/10.1007/978-981-10-7140-9.
Hernández-Martínez P, Ferré J, Escriche B. Broad-spectrum cross-resistance in Spodoptera exigua from selection with a marginally toxic Cry protein. Pest Management Science. 2009;65(6):645–650. https://doi.org/10.1002/ps.1725.
Pickett KE, Pearl M. Multilevel analyses of neighbourhood socioeconomic context and health outcomes: a critical review. Journal of Epidemiology & Community Health. 2001;55(2):111–122. https://doi.org/10.1136/jech.55.2.111.
Potter KA, Woods HA, Pincebourde S. Microclimatic challenges in global change biology. Global Change Biology. 2013;19(10):2932–2939. https://doi.org/10.1111/gcb.12257.
Progress on antibiotic resistance. Nature. 2018;562(7727):307. https://doi.org/10.1038/d41586-018-07031-7.
J S, Bharathi V. Bioactive potential from marine sponge Callyspongia diffusa-associated Pseudomonas fluorescens BCPBMS-1 and Penicillium citrinum. Microbial Bioactives. 2018;1(1):8–13.
J N S, Srinivasan VM, Devi CS. Novel anti-cancer compounds from marine actinomycetes: a review. Industrial Biotechnology. 2011.
Sabra W, Dietz D, Tjahjasari D, Zeng AP. Biosystems analysis and engineering of microbial consortia for industrial biotechnology. Engineering in Life Sciences. 2010;10(5):407–421. https://doi.org/10.1002/elsc.201000111.
Santero E, Floriano B, Govantes F. Harnessing the power of microbial metabolism. Current Opinion in Microbiology. 2016;31:63–69. https://doi.org/10.1016/j.mib.2016.03.003.
Shishir A, Roy A, Islam N, Rahman A, Khan SN, Hoq MM. Abundance and diversity of Bacillus thuringiensis in Bangladesh and their cry genes profile. Frontiers in Environmental Science. 2014;2:20. https://doi.org/10.3389/fenvs.2014.00020.
Taylor RG, Scanlon B, Döll P, Rodell M, van Beek R, Wada Y, et al. Groundwater and climate change. Nature Climate Change. 2013;3:322–329. https://doi.org/10.1038/nclimate1744.
Tender LM, Reimers CE, Stecher HA, Holmes DE, Bond DR, Lowy DA, et al. Harnessing microbially generated power on the seafloor. Nature Biotechnology. 2002;20(8):821–825. https://doi.org/10.1038/nbt716.
Toribio-Mateas M. Harnessing the power of microbiome assessment tools as part of neuroprotective nutrition and lifestyle medicine interventions. Microorganisms. 2018;6(2):35. https://doi.org/10.3390/microorganisms6020035.
van Belkum A, Bachmann TT, Lüdke G, Lisby JG, Kahlmeter G, Mohess A, et al. Developmental roadmap for antimicrobial susceptibility testing systems. Nature Reviews Microbiology. 2018;17:51–62. https://doi.org/10.1038/s41579-018-0098-9.
Vigneshvar S, Sudhakumari CC, Senthilkumaran B, Prakash H. Recent advances in biosensor technology for potential applications: an overview. Frontiers in Bioengineering and Biotechnology. 2016;4:11. https://doi.org/10.3389/fbioe.2016.00011.
Wackett LP. Microbial therapeutics. Microbial Biotechnology. 2017;10(3):666–667. https://doi.org/10.1111/1751-7915.12724.
Watkins C, Stanton C, Ryan CA, Ross RP. Microbial therapeutics designed for infant health. Frontiers in Nutrition. 2017;4:48. https://doi.org/10.3389/fnut.2017.00048.
View Dimensions
View Altmetric
Save
Citation
View
Share